COMMUNIQUÉS West-GlobeNewswire

Crown Bioscience présentera son expertise scientifique au EORTC-NCI-AACR
07/11/2018
Nouvelles données de modèles publiées, y compris les modèles cibles PDX du cancer de la prostate et les modèles cibles humanisés, pour l'évaluation d'inhibiteurs combinés de points de contrôle humains SAN DIEGO, 07 nov [...]
Chimerix to Present at the Stifel 2018 Healthcare Conference
07/11/2018
DURHAM, N.C., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals for the growing population of immunocompromised patients, today announced that M. Michelle [...]
MyoKardia to Present at the Credit Suisse 27th Annual Healthcare Conference
07/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today [...]
Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation
07/11/2018
TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) ("Revive" or the “Company”) , a specialty cannabis company focused on the research, development and [...]
Kezar Life Sciences to Present at Jefferies 2018 London Healthcare Conference
07/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
iTeos Therapeutics to Participate in Upcoming Conferences in November
07/11/2018
iTeos Therapeutics to Participate in Upcoming Conferences in November Gosselies, Belgium – November 7, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced that [...]
Forty Seven Inc. to Present at the Credit Suisse 27th Annual Healthcare Conference
07/11/2018
MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Forty Seven Inc. (NASDAQ:FTSV) a clinical-stage, immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today [...]
Evelo Biosciences to Present at Upcoming Investor Conferences in November
07/11/2018
CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing monoclonal microbials designed to act on the gut-body network for [...]
resTORbio to Present at Upcoming Investor Conferences in November
07/11/2018
BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- resTORbio, Inc. (Nasdaq: TORC), a clinical-stage biopharmaceutical company focused on helping people live healthier longer through the development and commercialization of novel [...]
Zogenix to Present at Stifel 2018 Healthcare Conference
07/11/2018
EMERYVILLE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that [...]
BrainStorm Cell Therapeutics to Present at November Clinical and Investor Conferences
07/11/2018
Highlights Preclinical Research and Continued Progress of NurOwn® Platform in ALS Pivotal Trial NEW YORK and PETACH TIKVAH, Israel, Nov. 07, 2018 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a [...]
Proteon Therapeutics Announces Third Quarter 2018 Financial Results
07/11/2018
WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]
Rhythm Pharmaceuticals to Present at Stifel 2018 Healthcare Conference
07/11/2018
BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]
The Joint Corp. Appoints Jake Singleton CFO
07/11/2018
SCOTTSDALE, Ariz., Nov. 07, 2018 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced its board of directors has appointed its Corporate [...]
MediPharm Labs Corp. Completes Major Extraction Milestone
07/11/2018
TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (the “ Company ” or “ MediPharm Labs ”) is pleased to announce that it has reached a significant milestone by completing the purification and [...]
CareDx to Participate in Upcoming Investor Conferences
07/11/2018
BRISBANE, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Allena Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
07/11/2018
-- Global Phase 3 URIROX-1™ Trial Ongoing; Expect to Initiate Second Phase 3 Study, URIROX-2™, in 2018 -- -- Presented Preclinical Proof-of-Concept Data on ALLN-346 at American College of Rheumatology (ACR/ARHP) Annual [...]
Acasti Pharma Schedules Second Quarter Fiscal 2019 Conference Call
07/11/2018
LAVAL, Quebec, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST) (the “Company” or “Acasti”), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
SeeThruEquity Initiates Coverage on HempAmericana
07/11/2018
NEW YORK, Nov. 07, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is proud to announce that SeeThruEquity has initiated coverage on the Company with a [...]

Pages